RPS Advisory Solutions’s AbbVie ABBV Stock Holding History

RPS Advisory Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$695K	Buy	3,195 +4	+0.1%	+$887	0.39%	37
2025 Q4	$729K	Buy	3,191 +3	+0.1%	+$683	0.34%	53
2025 Q3	$738K	Buy	3,188 +46	+1%	+$9.37K	0.36%	45
2025 Q2	$583K	Buy	3,142 +77	+3%	+$14.3K	0.32%	48
2025 Q1	$642K	Sell	3,065 -64	-2%	-$12.4K	0.45%	33
2024 Q4	$556K	Sell	3,129 -236	-7%	-$43.4K	0.35%	57
2024 Q3	$664K	Buy	3,365 +4	+0.1%	+$747	0.48%	40
2024 Q2	$576K	Buy	+3,361	New	+$557K	0.53%	43

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RPS Advisory Solutions's ABBV Position: Q1 2026 in Review

RPS Advisory Solutions increased its AbbVie (ABBV) stake by 0.13% in Q1 2026, buying an estimated $887 and bringing the position to 3,195 shares worth $695K. The position accounts for 0.39% of the portfolio, ranked #37.

RPS Advisory Solutions first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $738K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

RPS Advisory Solutions held 3,195 shares of AbbVie worth $695K as of Q1 2026.
RPS Advisory Solutions bought 4 AbbVie shares in Q1 2026, an estimated $887.
AbbVie made up 0.39% of RPS Advisory Solutions's portfolio in Q1 2026, its #37 holding.
RPS Advisory Solutions first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
RPS Advisory Solutions's AbbVie position peaked at $738K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on RPS Advisory Solutions's 13F filing for Q1 2026, filed 4 May 2026.